MeSH tree: N06.850.520.830.998
A machine learning (ML) model incorporating both clinical and genomic factors outperformed models based solely on either clinical or genomic data in predicting which patients with hormone receptor (HR)-positive, HER2-negative ...
Dec 13, 2024
0
24
Systematic reviews with time-to-event (TTE) analyses provide fundamental insights in many areas of research. TTE data indicate not only whether events (e.g. deaths) have occurred, but also how much time has elapsed between ...
Dec 2, 2024
0
12
Using a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise as a way to improve disease-free survival, finds a clinical trial published by The BMJ today.
Oct 23, 2024
0
28
Researchers from Peking University have conducted a comprehensive systematic review on the integration of machine learning into statistical methods for disease risk prediction models, shedding light on the potential of such ...
Oct 14, 2024
0
28
Population-based cancer survival is a key metric in evaluating the effectiveness of national cancer control policies and interventions. The "Healthy China 2030 Planning Outline" has set a goal to increase the overall cancer ...
Oct 14, 2024
0
12
People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy—proton beam therapy or intensity modulated radiation therapy (IMRT)—achieved equally high rates of ...
Sep 30, 2024
0
29
Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy improved progression-free survival (PFS) in patients ...
Aug 5, 2024
0
38
The artificial intelligence (AI) model GPT-4, known from its application in ChatGPT, shows impressive capabilities in biomedical research and can be used in many ways for simulations. A simulator developed at MedUni Vienna ...
Jul 11, 2024
0
66
Patients with pancreatic cancer who received chemotherapy both before and after surgery experienced longer survival rates than would be expected from surgery followed by chemotherapy, according to a new study from researchers ...
Jun 20, 2024
0
50
New data on prolonged prostate-specific antigen (PSA) progression and adverse events grouped by safety topic of interest from the PSMAfore study underscore the statistically significant and clinically meaningful radiographic ...
Jun 10, 2024
0
35
